Subsequent studies have reported that the expression of PZP in tumor tissues was lower than that in normal tissues, and the loss of PZP would promote the progression of breast cancer (Zheng et al., 2018; Wu et al., 2021), laying the foundation for the potential of PZP protein in tumor therapy. The gene discussed is PZP; the disease is neoplasm.